143 related articles for article (PubMed ID: 18164378)
1. Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastases.
Falchook GS; Wolff RA; Varadhachary GR
Gynecol Oncol; 2008 Mar; 108(3):515-9. PubMed ID: 18164378
[TBL] [Abstract][Full Text] [Related]
2. Clinical and pathological study of gastric cancer with ovarian metastasis.
Kobayashi O; Sugiyama Y; Cho H; Tsuburaya A; Sairenji M; Motohashi H; Yoshikawa T
Int J Clin Oncol; 2003 Apr; 8(2):67-71. PubMed ID: 12720097
[TBL] [Abstract][Full Text] [Related]
3. Effect of different treatment methods on survival in patients with pancreatic cancer.
Brasiūniene B; Juozaityte E; Inciūra A; Brasiūnas V; Barauskas G
Rocz Akad Med Bialymst; 2003; 48():66-9. PubMed ID: 14737944
[TBL] [Abstract][Full Text] [Related]
4. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
Gleisner AL; Assumpcao L; Cameron JL; Wolfgang CL; Choti MA; Herman JM; Schulick RD; Pawlik TM
Cancer; 2007 Dec; 110(11):2484-92. PubMed ID: 17941009
[TBL] [Abstract][Full Text] [Related]
5. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system metastases in epithelial ovarian carcinoma.
Larson DM; Copeland LJ; Moser RP; Malone JM; Gershenson DM; Wharton JT
Obstet Gynecol; 1986 Dec; 68(6):746-50. PubMed ID: 3024084
[TBL] [Abstract][Full Text] [Related]
7. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
8. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the pancreatic head: a community teaching hospital's experience from 1982 to 1992.
Falk J; Keidan R; Rigo PK; Dmuchowski C
Am Surg; 1999 Jan; 65(1):15-8. PubMed ID: 9915524
[TBL] [Abstract][Full Text] [Related]
10. Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma.
Yang R; Cheung MC; Byrne MM; Jin X; Montero AJ; Jones C; Koniaris LG
Arch Surg; 2010 Jan; 145(1):49-56. PubMed ID: 20083754
[TBL] [Abstract][Full Text] [Related]
11. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
[TBL] [Abstract][Full Text] [Related]
13. [Ovarian metastases of pancreatic ductal adenocarcinomas: the clinicopathological characteristics and outcomes of 10 cases].
Wang X; You Y; Ge YP; Ying HY; Cheng YJ; Bai CM
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):331-335. PubMed ID: 32375450
[No Abstract] [Full Text] [Related]
14. The differential response to chemotherapy of ovarian metastases from colorectal carcinoma.
Goéré D; Daveau C; Elias D; Boige V; Tomasic G; Bonnet S; Pocard M; Dromain C; Ducreux M; Lasser P; Malka D
Eur J Surg Oncol; 2008 Dec; 34(12):1335-9. PubMed ID: 18455357
[TBL] [Abstract][Full Text] [Related]
15. Role of surgery in the treatment of ovarian metastases from colorectal cancer.
Chung TS; Chang HJ; Jung KH; Park SY; Lim SB; Choi HS; Jeong SY
J Surg Oncol; 2009 Dec; 100(7):570-4. PubMed ID: 19722226
[TBL] [Abstract][Full Text] [Related]
16. Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival.
Strobel O; Hartwig W; Hackert T; Hinz U; Berens V; Grenacher L; Bergmann F; Debus J; Jäger D; Büchler M; Werner J
Ann Surg Oncol; 2013 Mar; 20(3):964-72. PubMed ID: 23233235
[TBL] [Abstract][Full Text] [Related]
17. Preoperative CA 19-9 level is an important prognostic factor in patients with pancreatic adenocarcinoma treated with surgical resection and adjuvant concurrent chemoradiotherapy.
Hallemeier CL; Botros M; Corsini MM; Haddock MG; Gunderson LL; Miller RC
Am J Clin Oncol; 2011 Dec; 34(6):567-72. PubMed ID: 21150564
[TBL] [Abstract][Full Text] [Related]
18. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
19. An aggressive therapeutic approach to carcinoma of the body and tail of the pancreas.
Ozaki H; Kinoshita T; Kosuge T; Yamamoto J; Shimada K; Inoue K; Koyama Y; Mukai K
Cancer; 1996 Jun; 77(11):2240-5. PubMed ID: 8635090
[TBL] [Abstract][Full Text] [Related]
20. Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis.
Lee SJ; Lee J; Lim HY; Kang WK; Choi CH; Lee JW; Kim TJ; Kim BG; Bae DS; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Jul; 66(2):229-35. PubMed ID: 19820936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
